A Phase 2 clinical trial investigating the anti-virus effects, kinetics and safety of GS-5806 in adults with RSV (Respiratory Syncytial Virus) infection

Mise à jour : Il y a 4 ans
Référence : EUCTR2014-002137-58

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to evaluate the effects of presatovir (GS-5806) on RSV viral load in RSV-positive adults hospitalized with acute respiratory infectious symptoms.


Critère d'inclusion

  • Respiratory Syncytial Virus (RSV) Infection